Launch Of Zenith AAA Iliac Legs With Flex Stent Gapping Designed To Have Increased Flexibility And Improved Conformability

Main Category: Medical Devices
Also Included In: Cardiovascular / Cardiology
Article Date: 19 Jul 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Cook Medical, the established world leader in developing advanced endovascular technologies to treat diseases of the aorta, today announces the launch of its innovative Zenith AAA Iliac Legs with Flex Stent Gapping. This new product, which has received CE marking, is designed to have increased flexibility and improved conformability, easing its path through tortuous patient anatomy. European availability will begin in July.

"As a modular device, the Zenith Flex endograft main body represents the highest order of engineering achievement in the pursuit of improved outcomes for patients undergoing EVAR. But until now, no company has addressed the issue of dramatically improving the other components - the ipsilateral and contralateral legs that seal the device below the aortic bifurcation. The development of the Zenith Flex AAA Legs is another step in Cook's ongoing journey to create innovative devices and technology that help physicians perform minimally invasive diagnostic and therapeutic procedures with the least possible trauma to the patient," explains Phil Nowell, global leader of Cook Medical's Aortic Intervention business unit. "In the near future, we expect to bring an even more advanced leg system to clinical trial that we expect may show even greater performance improvements."

The Zenith AAA Flex Leg external stents are shorter than those of its predecessor, with increased gaps between the stents. It is this design that improves flexibility and conformability, reducing the potential of the leg to kink. The device, like the Zenith Flex main body, is constructed of polyester graft material supported by stainless steel Z-stent bodies.

About Cook Medical

Cook Medical was one of the first companies to help popularise interventional medicine, pioneering many of the devices now commonly used worldwide to perform minimally invasive medical procedures. Today, the company integrates device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology, peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics. Cook is a past winner of the prestigious Medical Device Manufacturer of the Year Award from Medical Device & Diagnostic Industry magazine. For more information, visit www.cookmedical.com.